Celltech Biologics, Ixsys deal

Celltech Biologics (London:CTP) Ixsys Inc. CTP (Slough, U.K.) will manufacture Vitaxin, Ixsys’ humanized antibody to inhibit angiogenesis associated with most cancers and certain ophthalmic diseases...